Medicare Enrolled
Dr. Nalini Prasad
Neurology · North Bergen, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Prasad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prasad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Prasad
Dr. Nalini Prasad is a neurology specialist in North Bergen, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Prasad performed 1,125 Medicare services across 899 unique beneficiaries.
Between the years covered by Open Payments, Dr. Prasad received a total of $11,292 from 58 pharmaceutical and/or device companies across 583 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Prasad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in NJ
$11,292 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,125
Medicare services
Top 33% in NJ for neurology
899
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
342 | $105 | $245 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
135 | $135 | $368 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
132 | $74 | $200 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
124 | $89 | $227 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
64 | $409 | $1,037 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
62 | $186 | $529 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
50 | $36 | $95 |
| Abnormal eye movement test with recording A test that records and evaluates eye movements to check for abnormalities. |
50 | $22 | $67 |
| Abnormal eye movement test with recording A test that records eye movements in three different positions to check for abnormalities. |
50 | $25 | $71 |
| Abnormal eye movement test with moving target recording This test evaluates eye movements by tracking them while the patient focuses on a moving target. The results are recorded for analysis. |
50 | $16 | $45 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
50 | $116 | $267 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $57 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,292
Total received (2018-2024)
Avg $1,613/year across 7 years
Top 23% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
583
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,241 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,361
2023
$2,551
2022
$2,248
2021
$1,075
2020
$702
2019
$662
2018
$692
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$437
Lundbeck LLC
$409
Otsuka America Pharmaceutical, Inc.
$326
EMD Serono, Inc.
$301
Neurocrine Biosciences, Inc.
$266
PFIZER INC.
$239
MDD US Operations, LLC
$239
Lilly USA, LLC
$160
Amneal Pharmaceuticals LLC
$153
Vanda Pharmaceuticals Inc.
$125
Axsome Therapeutics, Inc.
$125
Teva Pharmaceuticals USA, Inc.
$106
SK Life Science, Inc.
$73
UCB, Inc.
$69
Kyowa Kirin, Inc.
$64
Eisai Inc.
$64
Sumitomo Pharma America, Inc.
$59
Avadel CNS Pharmaceuticals, LLC
$48
GE HEALTHCARE
$31
JAZZ PHARMACEUTICALS INC.
$19
ARGENX US, INC.
$19
Acorda Therapeutics, Inc
$15
Neurelis, Inc.
$14
Top 3 companies account for 34.9% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$994
ABBVIE INC.
$921
Lundbeck LLC
$906
Amneal Pharmaceuticals LLC
$685
Lilly USA, LLC
$530
Teva Pharmaceuticals USA, Inc.
$516
MDD US Operations, LLC
$477
Sunovion Pharmaceuticals Inc.
$446
SK Life Science, Inc.
$409
Neurocrine Biosciences, Inc.
$393
US WorldMeds, LLC
$345
Otsuka America Pharmaceutical, Inc.
$343
IMPEL PHARMACEUTICALS INC.
$314
PFIZER INC.
$294
AbbVie Inc.
$246
Eisai Inc.
$242
UCB, Inc.
$222
Vanda Pharmaceuticals Inc.
$196
Sumitomo Pharma America, Inc.
$193
Kyowa Kirin, Inc.
$177
Alexion Pharmaceuticals, Inc.
$169
Adamas Pharmaceuticals, Inc.
$150
GENZYME CORPORATION
$148
Allergan, Inc.
$135
Axsome Therapeutics, Inc.
$125
CSL Behring
$117
Amgen Inc.
$113
Biogen, Inc.
$109
Boston Scientific Corporation
$103
Penumbra, Inc.
$96
Acorda Therapeutics, Inc
$95
Novartis Pharmaceuticals Corporation
$86
ACADIA Pharmaceuticals Inc
$84
Celgene Corporation
$75
Neurelis, Inc.
$72
CATALYST PHARMACEUTICALS, INC.
$64
Avion Pharmaceuticals
$62
Azurity Pharmaceuticals, Inc.
$61
JAZZ PHARMACEUTICALS INC.
$59
Abbott Laboratories
$56
Impax Laboratories, Inc.
$56
Avadel CNS Pharmaceuticals, LLC
$48
Biohaven Pharmaceutical Holding Company Ltd.
$43
LivaNova USA, Inc.
$33
GE HEALTHCARE
$31
ARGENX US, INC.
$31
Genentech USA, Inc.
$29
Medtronic USA, Inc.
$27
Scilex Pharmaceuticals Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$24
BOSTON SCIENTIFIC CORPORATION
$23
Collegium Pharmaceutical, Inc.
$15
Avanir Pharmaceuticals, Inc.
$14
Catalyst Pharmaceuticals, Inc.
$14
Egalet US Inc
$14
Mallinckrodt Hospital Products Inc.
$12
Biohaven Pharmaceuticals, Inc.
$12
Merz Pharmaceuticals, LLC
$12
Top 3 companies account for 25.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Apokyn · Austedo XR · Auvelity · BOTOX · Briviact · CREXONT · DUOPA · Dhivy · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · FIRDAPSE · Fycompa · GOCOVRI · Gocovri · HETLIOZ · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LUMRYZ · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · ONGENTYS 50MG CAPSULES 30 · Ongentys · PANZYGA · PONVORY · QULIPTA · RED 72 · REXULTI · RYTARY · SOLIRIS · SPRIX · Trudhesa · UBRELVY · VALTOCO · VERCISE · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · Xadago · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,313
Per 100K population
184.8
County median income
$90,032
Nearest hospital
PALISADES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Prasad is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Prasad experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Prasad performed 342 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Prasad receive payments from pharmaceutical companies?
Yes. Dr. Prasad received a total of $11,292 from 58 companies across 583 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Prasad's costs compare to other neurologists in North Bergen?
Dr. Prasad's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Prasad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in North Bergen
Browse neurologists in North Bergen ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology